{{Rsnum
|rsid=5028843
|Gene=SLC2A9
|Chromosome=4
|position=9939182
|Orientation=plus
|GMAF=0.2544
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=SLC2A9
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 4.7 | 50.0 | 45.3
| HCB | 0.0 | 2.2 | 97.8
| JPT | 0.0 | 2.2 | 97.8
| YRI | 15.9 | 55.6 | 28.6
| ASW | 0.0 | 0.0 | 0.0
| CHB | 0.0 | 2.2 | 97.8
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}
{{PMID Auto
|PMID=19877038
|Title=Role of the urate transporter SLC2A9 gene in susceptibility to gout in New Zealand M&#x101;ori, Pacific Island, and Caucasian case-control sample sets
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}